Olli Keränen is the CEO and founder of Medtentia.
Olli has a strong background in research and development of medical devices including six years of experience working in the clinical academic area of cardiovascular surgery.
In addition, Olli has more than 30 years of experience in international sales and marketing, as well as business development. He holds several intellectual property inventions in the field of cardiology.
During his extensive career, Olli has held executive positions in various biotechnology and medical technology companies, including Xenerate AB, Jomed Health Care, BOC Health Care, and Ahlstrom Oyj.